Download PDF

Other users also viewed these articles

How many patients with rheumatic diseases and TNF inhibitors treatment have latent tuberculosis? Noemi Busquets-Pérez, Andrés Ponce, Vera Ortiz-Santamaria, Juanjosé de Agustín de Oro, Yolanda León Hernández-Rico, Imma Vidal, Carolina Alfonso, Sonia Argemí, Blanca Muñoz, Fernando Quispe, Ana Carolina Díaz, Salvador Campos, Teresa Mariné Hernández, Miquel Torres, Xavier Surís
10.1016/j.reumae.2016.05.010
Quality of life of patients with rheumatic diseases Lourdes Villalobos-Sánchez, Boris Blanco-Cáceres, Javier Bachiller-Corral, María Teresa Rodríguez-Serrano, Mónica Vázquez-Díaz, Pablo Lázaro y de Mercado
10.1016/j.reumae.2023.06.002
Recommendations for the Use of Parenteral Methotrexate in Rheumatic Diseases Jesús Tornero Molina, Jaime Calvo Alen, Javier Ballina, María Ángeles Belmonte, Francisco J. Blanco, Miguel Ángel Caracuel, Jordi Carbonell, Héctor Corominas, Eugenio Chamizo, Cristina Hidalgo, José Román Ivorra, José Luis Marenco, José Vicente Moreno Muelas, Santiago Muñoz-Fernández, Joan M. Nolla, Trinidad Pérez, Raimon Sanmarti, Pilar Trenor, Claudia Urrego, Javier Vidal, José Rosas Gomez de Salazar
10.1016/j.reumae.2016.12.003